{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:54:58Z","timestamp":1767830098755,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Taipei Blood Centre"},{"name":"TBSF"},{"name":"Taiwan CDC"},{"name":"Taiwan Ministry of Health and Welfare"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.biologicals.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T09:44:54Z","timestamp":1460281494000},"page":"183-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine"],"prefix":"10.1016","volume":"44","author":[{"given":"Kun-Teng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiu-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pin-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao-Jung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Ron","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Liang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Yang-Chih","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Fang","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Der-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2016.01.003_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.biologicals.2016.01.003_bib2","doi-asserted-by":"crossref","first-page":"e2067","DOI":"10.1371\/journal.pntd.0002067","article-title":"Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development","volume":"7","author":"Huang","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.biologicals.2016.01.003_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biologicals.2013.02.002","article-title":"Neutralization of five subgenotypes of enterovirus 71 by Taiwanese human plasma and Taiwanese plasma derived intravenous immunoglobulin","volume":"41","author":"Wu","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2016.01.003_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","article-title":"An apparently new enterovirus isolated from patients with disease of the central nervous system","volume":"129","author":"Schmidt","year":"1974","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biologicals.2016.01.003_bib5","doi-asserted-by":"crossref","first-page":"e51996","DOI":"10.1371\/journal.pone.0051996","article-title":"Enterovirus 71-induced neurological disorders in young gerbils, Meriones unguiculatus: development and application of a neurological disease model","volume":"7","author":"Yao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2016.01.003_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJM199909233411302","article-title":"Neurologic complications in children with enterovirus 71 infection","volume":"341","author":"Huang","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biologicals.2016.01.003_bib7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(12)61764-4","article-title":"Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2016.01.003_bib8","doi-asserted-by":"crossref","first-page":"e1737","DOI":"10.1371\/journal.pntd.0001737","article-title":"Challenges to licensure of enterovirus 71 vaccines","volume":"6","author":"Lee","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.biologicals.2016.01.003_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1875-9572(08)60023-6","article-title":"Enterovirus 71 in Taiwan","volume":"49","author":"Chang","year":"2008","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.biologicals.2016.01.003_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcv.2006.05.009","article-title":"Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis","volume":"37","author":"Wang","year":"2006","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.biologicals.2016.01.003_bib11","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2012.03.010","article-title":"Safety and immunogenicity of a novel human enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, phase I clinical trial","volume":"30","author":"Li","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2016.01.003_bib12","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1517\/14712598.2014.935330","article-title":"Update on the development of enterovirus 71 vaccines","volume":"14","author":"YA1","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.biologicals.2016.01.003_bib13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/cid\/ciu852","article-title":"Review of enterovirus 71 vaccines","volume":"60","author":"Chong","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2016.01.003_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jmv.2209","article-title":"Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71","volume":"67","author":"Nagata","year":"2002","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.biologicals.2016.01.003_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01317855","article-title":"Neurovirulence in cynomolgus monkeys of enterovirus 71 isolated from a patient with hand, foot and mouth disease","volume":"56","author":"Hashimoto","year":"1978","journal-title":"Arch Virol"},{"key":"10.1016\/j.biologicals.2016.01.003_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2990.1982.tb00269.x","article-title":"Pathogenicity of a poliomyelitis-like disease in monkeys infected orally with enterovirus 71: a model for human infection","volume":"8","author":"Hashimoto","year":"1982","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.biologicals.2016.01.003_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.virol.2012.06.026","article-title":"The effect of enterovirus 71 immunization on neuropathogenesis and protein expression profiles in the thalamus of infected rhesus neonates","volume":"432","author":"Chen","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.biologicals.2016.01.003_bib18","doi-asserted-by":"crossref","first-page":"e57591","DOI":"10.1371\/journal.pone.0057591","article-title":"Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2016.01.003_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00705-011-1198-2","article-title":"Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice","volume":"157","author":"Liu","year":"2012","journal-title":"Arch Virol"},{"key":"10.1016\/j.biologicals.2016.01.003_bib20","doi-asserted-by":"crossref","first-page":"14753","DOI":"10.1073\/pnas.1217563110","article-title":"Transgenic mouse model for the study of enterovirus 71 neuropathogenesis","volume":"110","author":"Fujii","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2016.01.003_bib21","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1128\/JVI.06103-11","article-title":"A\u00a0non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection","volume":"86","author":"Khong","year":"2012","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biologicals.2016.01.003_bib22","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1128\/JVI.01798-07","article-title":"Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD\/SCID mouse infection model","volume":"82","author":"Arita","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biologicals.2016.01.003_bib23","doi-asserted-by":"crossref","first-page":"e59501","DOI":"10.1371\/journal.pone.0059501","article-title":"Adaptation of enterovirus 71 to adult interferon deficient mice","volume":"8","author":"Caine","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2016.01.003_bib24","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1128\/JVI.78.15.7916-7924.2004","article-title":"A\u00a0mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection","volume":"78","author":"Wang","year":"2004","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biologicals.2016.01.003_bib25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.micinf.2011.04.004","article-title":"A\u00a0mouse muscle-adapted enterovirus 71 strain with increased virulence in mice","volume":"13","author":"Wang","year":"2011","journal-title":"Microbes Infect"},{"key":"10.1016\/j.biologicals.2016.01.003_bib26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.vaccine.2011.11.087","article-title":"Selection and characterization of vaccine strain for enterovirus 71 vaccine development","volume":"30","author":"Chang","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2016.01.003_bib27","first-page":"493","article-title":"A\u00a0simple method of estimating fifty per cent endpoint","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"10.1016\/j.biologicals.2016.01.003_bib28","doi-asserted-by":"crossref","first-page":"e34834","DOI":"10.1371\/journal.pone.0034834","article-title":"Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates","volume":"7","author":"Chou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2016.01.003_bib29","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbrc.2009.09.103","article-title":"Generation of neutralizing monoclonal antibodies against enterovirus 71 using synthetic peptides","volume":"390","author":"Li","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biologicals.2016.01.003_bib30","doi-asserted-by":"crossref","first-page":"e20005","DOI":"10.1371\/journal.pone.0020005","article-title":"Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2016.01.003_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biologicals.2004.07.002","article-title":"Potency of pertussis component in the DTP vaccine \u2013 an overview of three decade study in Poland","volume":"32","author":"Gzyl","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2016.01.003_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biologicals.2012.10.003","article-title":"Analyzing titers of antibodies against bacterial and viral antigens, and bacterial toxoids in the intravenous immunoglobulins utilized in Taiwan","volume":"41","author":"Wu","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2016.01.003_bib33","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1016\/j.vaccine.2004.03.039","article-title":"Mucosal immunisation of murine neonates using whole cell and acellular pertussis vaccines","volume":"22","author":"Hale","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2016.01.003_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/viro.1999.9695","article-title":"Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis","volume":"257","author":"Guirakhoo","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.biologicals.2016.01.003_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1423-0127-21-31","article-title":"Animal models of enterovirus 71 infection: applications and limitations","volume":"21","author":"Wang","year":"2014","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.biologicals.2016.01.003_bib36","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.biologicals.2016.01.003_bib37","first-page":"504563","article-title":"A\u00a0laboratory evaluation of medicinal herbs used in china for the treatment of hand, foot, and mouth disease","volume":"2013","author":"Chen","year":"2013","journal-title":"Evid Based Complement Altern Med"},{"key":"10.1016\/j.biologicals.2016.01.003_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.virusres.2012.05.019","article-title":"Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71","volume":"167","author":"Zhang","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.biologicals.2016.01.003_bib39","doi-asserted-by":"crossref","first-page":"831282","DOI":"10.1155\/2012\/831282","article-title":"Immunological evaluation and comparison of different EV71 vaccine candidates","volume":"2012","author":"Chou","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.biologicals.2016.01.003_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.micpath.2006.12.002","article-title":"The VP1 structural protein of enterovirus 71 interacts with human ornithine decarboxylase and gene trap ankyrin repeat","volume":"42","author":"Yeo","year":"2007","journal-title":"Microb Pathog"},{"key":"10.1016\/j.biologicals.2016.01.003_bib41","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/INF.0000000000000711","article-title":"Clinical analysis of 134 children with nervous system damage caused by enterovirus 71 infection","volume":"34","author":"Hu","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.biologicals.2016.01.003_bib42","doi-asserted-by":"crossref","first-page":"876241","DOI":"10.1155\/2012\/876241","article-title":"Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis","volume":"2012","author":"Wang","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.biologicals.2016.01.003_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/biol.1999.0180","article-title":"Mutual interactions between DTaP-IPV and Haemophilus influenzae type b (Hib)-conjugated vaccines in laboratory animal models","volume":"27","author":"Shams","year":"1999","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2016.01.003_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/biol.1993.1046","volume":"21","author":"Dular","year":"1993","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2016.01.003_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.01375-14","article-title":"Complete genome sequence of human enterovirus strain 71 (EV71\/Taipei\/3118\/2011), isolated from a patient in Taiwan","volume":"3","author":"Lin","year":"2015","journal-title":"Genome Announc"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510561600004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510561600004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T22:00:49Z","timestamp":1572991249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104510561600004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S104510561600004X"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2016.01.003","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}